IBRX Immunitybio Inc
Company Analysis
Latest News
🟢 IBRX extends move to 5.4% up
IBRX is trading at $9.23, up 5.4% versus the comparison close of $8.76 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX soars 5% on Russell 1000 inclusion hopes and upcoming Anktiva catalysts
IBRX is trading 5% up today at $9.19, extending a strong multi-day rally as investors anticipate potential inclusion in the Russell 1000 index and forthcoming...
🟢 IBRX makes sharp 10.2% jump
IBRX is trading at $8.59, up 10.2% versus the comparison close of $7.79 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX extends move to 5.5% up
IBRX is trading at $8.22, up 5.5% versus the comparison close of $7.79 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX is trading 4% up today on retail interest and short-squeeze speculation
IBRX is trading about 4% up now at $8.11 on elevated retail interest and short-squeeze speculation, extending its multi-day rebound while outperforming a...
🟢 IBRX extends move to 5.1% up
IBRX is trading at $7.69, up 5.1% versus the comparison close of $7.32 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX surges 4.6% on speculation of Russell 1000 inclusion
IBRX is trading 4.6% up now at $7.66, driven by retail trader speculation regarding its potential inclusion in the Russell 1000 Index. * With a market cap of...
🟢 IBRX extends move to 5.1% up
IBRX is trading at $7.58, up 5.1% versus the comparison close of $7.22 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Immunitybio Inc extends move to 5.1% up
IBRX is trading at $7.06, up 5.1% versus the comparison close of $6.72 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Immunitybio Inc is trading 4.9% up today as investors anticipate Russell index inclusion
• Immunitybio Inc is trading 4.9% higher at $7.05 as it garners retail attention ahead of the Russell index reconstitution later this month. • Investors are...
🔴 Immunitybio Inc extends move to 5.1% down
IBRX is trading at $6.76, down 5.1% versus the comparison close of $7.13 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Immunitybio Inc is trading 4.1% down today as it gives back recent gains
Immunitybio Inc is trading 4.1% down at $6.84 as the stock gives back a portion of last week’s gains despite an absence of fresh, company-specific...
ImmunityBio Reports Voting Results from 2026 Annual Shareholder Meeting
ImmunityBio (IBRX) announced the official voting results from its 2026 Annual Meeting of Stockholders held on June 9, 2026. Shareholders approved all proposals...
ImmunityBio Jumps 11%, Led by 431% Revenue Surge and ANKTIVA Sales
ImmunityBio (IBRX) shares gained 11% following the release of its fourth-quarter financial results. Net product revenue surged 431% year-over-year to $38.3...
🟢 Immunitybio Inc is trading 5.06% up today amid a broader market rally and geopolitical de-escalation
Immunitybio Inc is trading at $7.27 (+5.06%) as the stock rebounds alongside a broader recovery in U.S. equity markets. • The upward move aligns with gains in...
🟢 Immunitybio Inc is trading 4.5% up today, recovering from last week's macro-driven selloff
Immunitybio Inc is trading 4.5% up at $7.23 as it recovers from last week’s macro-driven selloff in alignment with a broader market rebound. • The upward move...
🔴 Immunitybio Inc is trading 5.5% down today on macro pressure and reduced rate cut hopes
Immunitybio Inc is trading 5.5% down at $6.89 as U.S. equities face a broad selloff and risk assets come under pressure. • The decline appears macro-driven,...
🔴 Immunitybio Inc is trading 4.1% down today amid broad market selloff
Immunitybio Inc is trading 4.1% down at $6.99 today, primarily driven by a broad market selloff and general risk-off sentiment. • The stock's decline appears...
ImmunityBio Shares Sink, FDA Questions ANKTIVA Bladder Cancer Trial Data
ImmunityBio (IBRX) shares declined on May 29, 2026. The U.S. Food and Drug Administration (FDA) is currently reviewing a supplemental application to expand the...
🔴 IBRX is trading 4.7% down today on class action reminders and profit taking
IBRX is trading 4.7% down at $7.36 as traders react to ongoing securities class action reminders and volatility-driven profit taking. • Legal firms are...